How to Get Vyvanse in South Dakota

South Dakota Prescribing Law for Schedule II Stimulants

South Dakota allows MDs, DOs, NPs, and PAs to prescribe Schedule II controlled substances, including lisdexamfetamine, provided they hold a current South Dakota medical license and an active DEA registration. NPs in South Dakota gained full prescriptive authority in 2017 under SDCL 36-9A, removing the prior collaborative agreement requirement for controlled substances.

A prescriber must complete a face-to-face or real-time audio-visual evaluation before writing an initial Schedule II prescription. The DEA's 2023 telemedicine rule extension maintained that initial Schedule II prescriptions may be issued via live video visits if the encounter meets the same standard of care as an in-person exam. Paper prescriptions are no longer the only option: South Dakota permits electronic prescribing of controlled substances (EPCS) through certified pharmacy systems. Most chain and independent pharmacies in Sioux Falls, Rapid City, and Aberdeen accept EPCS for Schedule II drugs.

One wrinkle matters. South Dakota law limits initial Schedule II prescriptions to a 30-day supply with no refills, matching federal DEA rules. Prescribers can write up to three sequential 30-day prescriptions at a single visit, each with a "do not fill before" date, reducing the frequency of required follow-ups to once every 90 days after stabilization.

Telehealth Pathways for Vyvanse in South Dakota

Getting a Vyvanse prescription through telehealth in South Dakota is straightforward if you choose a provider licensed in the state. South Dakota's telehealth parity law (SDCL 36-36) recognizes synchronous video visits as equivalent to in-person encounters for prescribing purposes, including Schedule II medications.

A typical telehealth evaluation for ADHD takes 45 to 60 minutes. The clinician will review symptom history using validated instruments such as the Adult ADHD Self-Report Scale (ASRS-v1.1), rule out comorbid conditions like anxiety or substance use disorder, and check prescription drug monitoring program (PDMP) records. South Dakota requires all prescribers to query the South Dakota PDMP before issuing a Schedule II prescription for the first time.

Telehealth platforms that operate in South Dakota typically employ psychiatrists or psychiatric nurse practitioners with SD licenses. Patients in rural areas of western South Dakota, where the nearest psychiatrist may be 150+ miles away, benefit most from this model. According to HRSA data, 48 of South Dakota's 66 counties are designated Mental Health Professional Shortage Areas as of 2025.

After the initial evaluation, follow-up visits are usually 15 to 20 minutes and can occur via phone or video. Most plans require at least one follow-up within 30 days of starting a stimulant, then every 90 days once the dose is stable.

What Labs and Screening Are Required Before Starting Vyvanse

No specific lab panel is FDA-mandated before initiating lisdexamfetamine. The prescriber will focus on clinical evaluation.

Baseline vitals are standard. Heart rate and blood pressure should be documented before and after dose titration. The American Academy of Pediatrics 2019 ADHD guideline recommends vital sign monitoring at every visit during stimulant therapy. For adults, the American Heart Association's 2008 scientific statement advises a cardiovascular history screen but does not require routine ECG unless the patient has known cardiac disease or symptoms like syncope or palpitations.

Some prescribers order a baseline comprehensive metabolic panel (CMP) and CBC, particularly when the patient is on other medications or has a history of hepatic impairment. Lisdexamfetamine is a prodrug that requires enzymatic hydrolysis in red blood cells to release active d-amphetamine [1]. This mechanism was characterized in the original pharmacokinetic studies by Pennick (2010), confirming that red blood cell hydrolysis, not hepatic metabolism, drives conversion.

For patients being evaluated for binge eating disorder, clinicians may also assess BMI, metabolic markers (HbA1c, lipid panel), and screen for purging behaviors, since lisdexamfetamine is not approved for weight loss and carries misuse potential.

South Dakota Medicaid and Insurance Coverage

Brand-name Vyvanse is not covered under South Dakota Medicaid's preferred drug list. This is a significant barrier. South Dakota's fee-for-service Medicaid program uses a closed formulary for stimulants, preferring generic methylphenidate and mixed amphetamine salts over branded lisdexamfetamine.

Patients on SD Medicaid have two main options. First, generic lisdexamfetamine became available in August 2023 after Takeda's patent settlement allowed early entry by manufacturers including Alvogen, Teva, and Sandoz. Generic lisdexamfetamine may be obtainable through Medicaid with prior authorization, though coverage varies by quarter as the state updates its preferred drug list. Second, if generic lisdexamfetamine is also denied, the prescriber can submit a medical necessity appeal documenting prior trial and failure of at least two preferred stimulants.

Commercial insurers in South Dakota (Avera Health Plans, Sanford Health Plan, DAKOTACARE) generally cover generic lisdexamfetamine on Tier 2 or Tier 3 after prior authorization. The prior authorization form typically requires:

• A confirmed DSM-5 diagnosis of ADHD or binge eating disorder
• Documentation of trial and response to at least one preferred agent
• Prescriber's DEA number and NPI
• Duration of requested therapy (usually 12 months)

Cash-pay pricing for generic lisdexamfetamine in South Dakota ranges from $30 to $80 for a 30-day supply at major chains, based on GoodRx data as of early 2026. Brand Vyvanse remains over $350 without insurance. Takeda's Vyvanse coupon program can reduce copays for commercially insured patients to as low as $30 per month but does not apply to government insurance (Medicaid, Medicare, TRICARE).

Dose Forms, Titration, and What to Expect

Lisdexamfetamine comes as oral capsules (10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg) and chewable tablets (10 mg through 60 mg). The capsule can be opened and dissolved in water for patients who have difficulty swallowing, per the FDA-approved prescribing information.

Most clinicians start adults at 30 mg once daily, taken in the morning. Titration occurs in 10 mg or 20 mg increments at weekly intervals until optimal response is reached, up to a maximum of 70 mg daily. In the key adult ADHD trial by Wigal et al. (2017), forced-dose titration to 30 mg, 50 mg, and 70 mg produced significant improvements in ADHD-RS-IV scores compared to placebo across all dose groups, with the 70 mg dose showing the largest effect size (Cohen's d = 0.89) [2].

The prodrug mechanism gives lisdexamfetamine a smoother pharmacokinetic profile than immediate-release amphetamine. Peak plasma concentration of d-amphetamine occurs approximately 3.5 hours after oral dosing, and clinical effects typically last 10 to 14 hours [3]. Patients should expect noticeable symptom improvement within 1 to 2 hours of the first dose, though optimal dosing may take 3 to 5 weeks to establish.

Common side effects include decreased appetite (27%), dry mouth (26%), insomnia (19%), and headache (12%), based on pooled data from the FDA label [3]. These rates were consistent in the adult ADHD population across registration trials.

Transferring a Vyvanse Prescription to South Dakota

Transferring a Schedule II prescription between states involves specific rules. A prescription written by a provider in another state can be filled at a South Dakota pharmacy if the prescriber is licensed and DEA-registered in the originating state. South Dakota does not require out-of-state prescribers to hold an SD license for a one-time fill.

For ongoing treatment after relocating to South Dakota, patients need to establish care with an SD-licensed prescriber. The previous prescriber can send medical records (diagnostic evaluation, treatment history, current dose) to the new provider, who can then write a new prescription under their own DEA registration. This transition typically takes 2 to 4 weeks. To avoid a gap in medication, patients should request a 30-day bridge prescription from their current provider before the move.

PDMP data does not automatically transfer between states. The new SD prescriber will query the South Dakota PDMP at the first visit and may request PDMP records from the prior state through the Interstate Data Sharing Hub (PMPInterConnect), which South Dakota participates in.

503A Compounding Pharmacies in South Dakota

Licensed 503A compounding pharmacies in South Dakota can compound lisdexamfetamine preparations with a valid patient-specific prescription. This option is occasionally used for patients who need a non-standard dose form (oral solution at a concentration not commercially available) or who cannot tolerate inactive ingredients in the manufactured product.

Compounded lisdexamfetamine is not a cost-saving alternative to generic capsules in most cases. 503A pharmacies must source the active ingredient from FDA-registered suppliers, and the compounded product does not carry FDA approval for bioequivalence. The FDA's 2023 guidance on 503A compounding requires that compounded drugs be prepared in response to individual prescriptions and not produced in bulk for office stock.

South Dakota's Board of Pharmacy oversees 503A facilities in the state. Patients considering a compounded formulation should confirm that the pharmacy holds a current SD compounding license and meets USP 795/800 standards.

Scheduling Your First Appointment

The most efficient pathway from initial contact to filled prescription looks like this for a South Dakota resident:

Week 1: Schedule a telehealth or in-person evaluation with an SD-licensed prescriber (psychiatrist, NP, or PA). Complete intake forms and screening questionnaires. Gather any prior records of ADHD diagnosis or treatment.

Week 1-2: Attend the evaluation (45-60 minutes). If the prescriber confirms a diagnosis, they will send an electronic prescription to your chosen South Dakota pharmacy and query the PDMP.

Week 2-3: If prior authorization is required, the prescriber's office submits the PA form. Most commercial plans process PAs within 48 to 72 hours. Medicaid PAs may take up to 14 business days.

Week 2-4: Pick up or receive the filled prescription. Most pharmacies in Sioux Falls, Rapid City, Brookings, and Aberdeen stock generic lisdexamfetamine. Rural pharmacies may need 1 to 3 business days to order it.

Total time from first contact to medication in hand: 7 to 28 days, depending on insurance requirements. Patients paying cash with no PA needed can often fill the prescription within 48 hours of the initial visit.

"Before prescribing any Schedule II stimulant, I confirm the diagnosis meets DSM-5 criteria, screen for contraindications including uncontrolled hypertension and active substance use disorder, and review the state PDMP. Telehealth makes this accessible to rural patients who otherwise face long drives to the nearest specialist." This reflects the standard clinical workflow described in the APA Practice Guidelines for ADHD (2024).

According to the CDC's 2023 National Health Interview Survey, an estimated 6.1 million U.S. adults reported an ADHD diagnosis, representing 2.5% of the adult population [4]. South Dakota's adult ADHD prevalence tracks near the national average, yet specialist availability remains below the median for all states.